Spiro(4.5.)decane compounds
US5206247A · kind A · utility
17Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 1991 |
| Grant date | Apr 27, 1993 |
| Priority date | — |
| Expiry date | Sep 5, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compounds are 8-substituted 1-oxa-2-oxo-3,8-diazaspiro [4.5]decanes useful for the treatment of dyslipidaemiae, atherosclerosis and pathologies in which membrane lipid peroxidation plays an initiating and/or aggravating role. A compound disclosed is (R,S)-8-[3(3,5-di-tert.-butyl-4-hydroxyphenylthio)-2-hydroxypropyl]-1-oxa- 2oxo-3,8-diazaspiro [4.5]decane.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.